Effects of topically instilled bunazosin hydrochloride and other ocular hypotensive drugs on endothelin-1-induced constriction in rabbit retinal arteries

Japanese Journal of Ophthalmology

Volumn 48, Issue 5, 2004, Pages 465-469

  Okada, Yuji ^a   Ichikawa, Masaki ^a   Ishii, Kiyoshi ^b   Hara, Hideaki ^a,c  

^a SANTEN PHARMACEUTICAL CO LTD   (Japan)

^b SAITAMA RED CROSS HOSPITAL   (Japan)

^c GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Bunazosin; Endothelin 1; Ocular hypotensive drugs; Rabbit; Retinal arteries; Vasoconstriction

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BETAXOLOL; BUNAZOSIN; DORZOLAMIDE; ENDOTHELIN 1; NIPRADILOL; TIMOLOL MALEATE; TOPICAL AGENT; UNOPROSTONE ISOPROPYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG INSTILLATION; DRUG PENETRATION; DRUG POTENCY; EYE BLOOD FLOW; EYE PHOTOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RETINA ARTERY; RETINA DISEASE;

ADMINISTRATION, TOPICAL; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ENDOTHELIN-1; MALE; QUINAZOLINES; RABBITS; RETINAL ARTERY; VASOCONSTRICTION;

EID: 6344240348     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10384-004-0108-5     Document Type: Article

References (24)

1. Zhao DY, Cioffi GA. Anterior optic nerve microvascular changes in human glaucomatous optic neuropathy. Eye 2000;14:445-449.
2. Yorio T. Krishnamoorthy R, Prasanna G. Endothelin: is it a contributor to glaucoma pathophysiology? J Glaucoma 2002;11: 259-270.
3. Gass A, Flammer J, Linder L, Romerio SC, Gasser P, Haefeli WE. Inverse correlation between endothelin-1-induced peripheral microvascular vasoconstriction and blood pressure in glaucoma patients. Graefes Arch Clin Exp Ophthalmol 1997;235:634-638.
4. Bunazosin, Andante. Detantol. E1015, E643, EA0643. Drugs R&D 1999;2(6):417-419.
5. Segawa K, Nishiyama K, Kurihara K, Okubo H, Ota K, Komemushi S. Phase-three clinical appraisal of bunazosin hydrochloride ophthalmic solution for primary open-angle glaucoma and ocular hypertension. Comparison with 0.1% dipivefrin hydrochloride ophthalmic solution. Ganka Rinsho Iho (Jpn Rev Clin Ophthalmol) 1994;88:1386-1390.
6. Azuma I, Kitazawa Y, Tsukahara S, Takase M, Shiose Y, Komemushi S. Long-term study of bunazosin hydrochloride ophthalmic solution in primary open-angle glaucoma and ocular hypertension. Atarashii Ganka (J Eye) 1994;11:631-635.
7. Azuma I, Kitazawa Y, Tsukahara S, Takase M, Shiose Y, Komemushi S. Phase three clinical trial of bunazosin hydrochloride ophthalmic solution for primary open angle glaucoma and ocular hypertension. A multicenter double-masked comparative study using 0.5% timolol maleate ophthalmic solution. Ganka Rinsho Iho (Jpn Rev Clin Ophthalmol) 1994;88:1280-1285.
8. Sugiyama T, Oku H, Moriya S, Shimizu K, Azuma I. Evaluation of bunazosin hydrochloride with a model of ocular circulation disturbance induced by endothelin-1. Nippon Ganka Gakkai Zasshi (J Jpn Ophthalmol Soc) 1994;98:63-68.
9. Mizuno K, Koide T, Yoshimura M, Araie M. Neuroprotective effect and intraocular penetration of nipradilol, a beta-blocker with nitric oxide donative action. Invest Ophthalmol Vis Sci 2001;42:688-694.
10. 2+ antagonist: ocular and periocular penetration after instillation. Invest Ophthalmol Vis Sci 2003;44:1169-1177.
11. Sugiyama T, Azuma I. Effect of UF-021 on optic nerve head circulation in rabbits. Jpn J Ophthalmol 1995;39:124-129.
12. Taniguchi T, Okada K, Haque M, Sugiyama K, Kitazawa Y. Effects of endothelin-1 on intraocular pressure and aqueous humor dynamics in the rabbit eye. Curr Eye Res 1994;13:461-464.
13. Yu DY, Su EN, Cringle SJ, Schoch C, Percicot CP, Lambrou GN. Comparison of the vasoactive effects of the docosanoid unoprostone and selected prostanoids on isolated perfused retinal arterioles. Invest Ophthalmol Vis Sci 2001;42:1499-1504.
14. Yu DY, Su EN, Cringle SJ, Alder VA, Yu PK, Desantis L. Effect of betaxolol, timolol and nimodipine on human and pig retinal arterioles. Exp Eye Res 1998;67:73-81.
15. Pillunat LE, Bohm AG, Koller AU, Schmitdt KG, Klemm M, Richard G. Effect of topical dorzolamide on optic nerve head blood flow. Graefes Arch Exp Ophthalmol 1999;237:495-500.
16. Tamaki Y, Araie M, Muta K. Effect of topical dorzolamide on tissue circulation in the rabbit optic nerve head. Jpn J Ophthalmol 1999;43:386-391.
17. Hosokawa A, Nagayama T, Yoshida M, et al. Facilitation and inhibition by endothelin-1 of adrenal catecholamine secretion in anesihetized dogs. Eur J Pharmacol 2000;397:55-61.
18. Nguyen TD, Vequaud P, Thorin E. Effects of endothelin receptor antagonists and nitric oxide on myogenic tone and alpha-adrenergic-dependent contractions of rabbit resistance arteries. Cardiovasc Res 1999;43:755-761.
19. Vila JM, Medina P, Segarra G, Aldasoro M, Noguera I, Lluch S. Endolhelin-1-induced potentiation of adrenergic responses in the rabbit pulmonary artery: role of thromboxane A(2). Eur J Pharmacol 2001;413:247-254.
20. 1-adrenoceptor antagonist, on the retinal artery diameter in rabbits [abstract]. Invest Ophthalmol Vis Sci 2003;44:E-abstract 134.
21. Sugiyama T, Moriya S, Oku H, Azuma I. Association of endothelin-1 with normal tension glaucoma: clinical and fundamental studies. Surv Ophthalmol 1995;39(Suppl):S49-S56.
22. Cellini M, Possati GL, Profazio V, Sbrocca M, Caramazza N, Caramazza R. Color Doppler imaging and plasma levels of endothelin-1 in low-tension glaucoma. Acta Ophthalmol Scand Suppl 1997;75:11-13.
23. Chakrabarti S, Cukiernik M, Hileeto D, Evans T, Chen S. Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy. Diabetes Metab Res Rev 2000;16:393-407.
24. Cellini M, Santiago L, Versura P, Caramazza R. Plasma levels of endothelin-1 in retinitis pigmentosa. Ophthalmologica 2002;216: 265-268.